Genix Pharmaceuticals (TSXV:GENX) Debt-to-Asset : 16.21 (As of Jan. 2025)

Genix Pharmaceuticals Debt-to-Asset Chart

Genix Pharmaceuticals Annual Data
	Trend	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23	Oct24
Debt-to-Asset		Get a 7-Day Free Trial					-	0.01	0.04	2.30	17.74

Genix Pharmaceuticals Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Debt-to-Asset	Get a 7-Day Free Trial															2.33	2.68	3.17	17.74	16.21

Competitive Comparison of Genix Pharmaceuticals's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genix Pharmaceuticals's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Debt-to-Asset falls into.

Genix Pharmaceuticals Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Genix Pharmaceuticals's Debt-to-Asset for the fiscal year that ended in Oct. 2024 is calculated as

Genix Pharmaceuticals's Debt-to-Asset for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals  (TSXV:GENX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Genix Pharmaceuticals Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Genix Pharmaceuticals Business Description